ACG Wealth’s BlackRock Health Sciences Trust BME Stock Holding History

ACG Wealth’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-323	Closed	-$14K	–	321
2022 Q2	$14K	Buy	+323	New	+$14K	﹤0.01%	633

Other funds holding BME

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Cornerstone Advisory Hunt Valley, Maryland $1.06B AUM 12.86% 1-Year Est. Return

ACG Wealth's BME Position: Q3 2022 in Review

ACG Wealth sold out of BlackRock Health Sciences Trust (BME) in Q3 2022, closing a stake of 323 shares — an estimated $14K sold.

ACG Wealth first reported a position in BME in Q2 2022 and held it in 1 quarter. The position peaked at $14K in Q2 2022. 62 funds tracked by Wall St. Rank hold BME as of Q3 2022.

ACG Wealth reported no remaining BlackRock Health Sciences Trust position as of Q3 2022 after selling out during the quarter.
ACG Wealth sold 323 BlackRock Health Sciences Trust shares in Q3 2022, an estimated $14K.
ACG Wealth first reported a position in BlackRock Health Sciences Trust in Q2 2022 and held it in 1 quarter.
ACG Wealth's BlackRock Health Sciences Trust position peaked at $14K in Q2 2022.
62 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.